Compounding is the process of creating a medication that’s tailored to the needs of an individual patient. Some patients may need medication in liquid form when the FDA-approved drug only comes in a pill. Drug compounding technology allows patients to receive treatment in a way that best suits their individual needs. 

​

Compounded drugs are prepared by state-licensed compounding pharmacies that meet FDA and state requirements, including quality standards. A pharmacy can compound medications of FDA-approved drugs that are in supply shortage like Semaglutide. Compounded drugs are not subject to the same lengthy, exhaustive FDA approval process required for brand new drugs and do not have to undergo clinical trials for safety, effectiveness, or manufacturing review as if it were a new treatment on the market. That has already been proven to the FDA. Compounded drugs are not “new” drugs, they are the same drug in a different form.

We are working with one of the few FDA approved large-scale compounded drug manufacturers, often referred to as FDA outsourcing facilities under the Drug Quality and Security Act (section 503B).

The manufacturer that we purchase from uses cutting-edge isolation and robotic manufacturing technologies. They conduct all analytical and microbiological testing in-house to maintain the absolute highest quality sterile injectable production that meets market demands.

No. Currently, we do not mail out any refrigerated medications including Semaglutide.

The Semaglutide injection is dispensed in multi-dose vials as opposed to the traditional auto-injector pens. Prescribed doses will be measured in “units” and not “milligrams”, so we will provide you with the necessary insulin syringes required for your dosing.

Your provider will prescribe a specific weekly dose that we will print on the label, similar to any other medication we dispense. The instructions on the label will indicate how many units of medication you will inject under the skin. For example, if your physician instructs you to inject 0.25mg every week, the corresponding injection dose will be 10 units every week.

We will dispense this medication as long as it remains on the FDA’s drug shortage list and the compounding pharmacy is able to manufacture it.

Subcutaneously (under the skin).

This compounded Semaglutide is stable for 28 days after opening. It is important to keep this medication refrigerated.

Nope! We will dispense the appropriate amount of insulin syringes you need based on your prescribed dose and frequency.